How the Utilization of Integrated Industry 4.0 Technologies will Radically Address Medical Data Integrity Concerns in Singapore
DOI:
https://doi.org/10.51483/IJAIML.2.1.2022.75-117Keywords:
Digital health, IoMT, Internet of medical things, Singapore, Telemedicine, innovation 4.0 technologies, Blockchain, Sharing of medical data with employers, Medical data integrityAbstract
Industry 4.0 in the pharmaceutical, medical devices, and healthcare sectors could have
a significant impact as they can help maximize productivity by analyzing the data of
patients. The application of Industry 4.0 technologies to the pharma, medical, and
healthcare sectors may also play an important role in addressing and helping overcome
the Covid-19 pandemic, thanks to the latest innovations in the space of biopharma and
biotech. This study will explore how the utilization of Blockchain can help to address
medical data security concerns to accelerate the utilization of digital health and
Telemedicine, which is one of the key concerns cited by both the general public and
industry experts, which might impact the adoption of the industrial 4.0 technologies.
This research focuses on the Singapore medical industry and on the opinions of
Singaporeans and the predictions of industry experts. Using qualitative methodology,
this research is exploratory in nature, given the early-stage developments in the
implementation of integrated 4.0 technologies in the digital health space. In addition,
this study aims to assess the future potential benefits of integrating these advanced
technologies into the medical and biopharma industries for the healthcare system of
Singapore and its citizens. Finally, this study will seek to contribute to the existing
literature in the fields of digital health, Blockchain-based health devices, Internet of
Medical Things (IoMT), and Telemedicine, and to the integrated use of these technologies
to create new value innovation opportunities and business models in the rapidly
expanding digital health space of Singapore.
,, , , ,
, , ,
.




